Welcome to our dedicated page for Trulieve Cannabis news (Ticker: TCNNF), a resource for investors and traders seeking the latest updates and insights on Trulieve Cannabis stock.
Trulieve Cannabis Corp. (TCNNF) generates frequent news across operations, finance, regulation, and product development, reflecting its role as a vertically integrated, multi-state cannabis operator. As an industry leading company with leading market positions in Arizona, Florida, and Pennsylvania, Trulieve’s announcements often cover expansion of its retail footprint, capital markets activity, and responses to evolving cannabis policy in the United States.
Investors and observers following Trulieve news will see regular updates on financial performance, such as quarterly results detailing revenue, gross margin, cash flow, and non-GAAP metrics like adjusted EBITDA and free cash flow. The company also issues press releases about conference calls and investor presentations, providing context on its operating strategy, retail network, and production capacity.
Trulieve’s news flow includes financing developments, such as private placements of senior secured notes, redemptions of existing debt, and related SEC filings. These items outline interest rates, maturities, security pledges, and intended use of proceeds for capital expenditures and general corporate purposes. Such updates are important for understanding the company’s capital structure and liquidity.
Operational news highlights new dispensary openings, licensing agreements, and market entries. For example, Trulieve has announced Trulieve-branded dispensaries in Ohio operated by a partner under license, as well as conditional approval for a Dispensing Organization license under the Texas Compassionate Use Program. Product-focused releases showcase new offerings, including additional flavors of Onward and Upward THC-infused beverages and other branded cannabis products.
Policy and regulatory developments also feature in Trulieve’s news, including its public support for marijuana rescheduling to Schedule III under the Controlled Substances Act. For users tracking TCNNF, this news page offers a centralized view of the company’s financial updates, expansion moves, product launches, and regulatory commentary over time.
Trulieve (OTCQX: TCNNF) announced that CEO Kim Rivers established an automatic securities disposition plan effective March 17, 2026. Sales may begin June 17, 2026 and continue until 2.5 million subordinate voting shares are sold, subject to daily volume limits, independent broker execution, and applicable U.S. and Canadian rules.
The ASDP is authorized by the compensation committee, restricts executive discretion, and will be reported under securities laws with filings accessible on SEDI and SEC systems.
Trulieve (OTCQX: TCNNF) will open a new medical cannabis dispensary in DeLand, Florida with a grand opening on March 20, 2026. The store at 1329 North Woodland Boulevard offers walk-in and express pickup, weekday and weekend hours, and carries Trulieve and partner brands.
Services include home delivery, online ordering, veteran discounts (20% with military ID) and a 60% first-time guest discount at Florida locations. Hours: Mon–Sat 9:00 a.m.–8:45 p.m.; Sun 10:00 a.m.–8:00 p.m.
Trulieve (OTCQX: TCNNF) announced a new medical cannabis dispensary in Lake Wales, Florida, opening with a grand celebration on March 13, 2026. The location at 1341 State Road 60 E will offer walk-in, express pickup, home delivery, and extended hours plus in-house and partner brands.
Trulieve (OTCQX: TCNNF) reported full year 2025 revenue of $1.2 billion with a 60% gross margin and GAAP gross profit of $711 million. The company generated record cash flow from operations of $273 million and free cash flow of $229 million in 2025.
Additional highlights include adjusted EBITDA of $427 million, net loss attributable to common shareholders of $116 million, year-end cash of $256 million, redemption of $368 million of notes due 2026, and conditional Texas dispensing approval.
Trulieve Cannabis Corp (OTCQX: TCNNF) will hold a conference call on February 26, 2026 at 8:30 AM ET to discuss its fourth quarter and full year 2025 financial results. CEO Kim Rivers and CFO Jan Reese will review financial and operating results via dial-in and live webcast.
Dial-in numbers and passcode are provided, and a replay will be archived at the company investor events page.
Trulieve (OTCQX: TCNNF) closed a second tranche of a private placement of 10.5% senior secured notes due 2030 for US$60.0 million, bringing aggregate issuance to US$200.0 million. Notes were issued at US$1,000 plus accrued interest of US$12.37 per US$1,000.
The offering was conducted on a best-efforts basis with Canaccord Genuity as sole agent and bookrunner. The company intends to use net proceeds for capital expenditures and general corporate purposes and will apply to list the Notes on the Canadian Securities Exchange after the four-month hold period.
Trulieve (OTCQX: TCNNF) announced it will open a new medical cannabis dispensary in Fort Myers, Florida, with a grand opening on January 30, 2026. Trulieve Fort Myers Beach at 17274 San Carlos Boulevard will offer walk-in and express pickup, home delivery across Florida, and retail hours of 9:00 a.m.–8:45 p.m. Monday–Saturday and 10:00 a.m.–8:00 p.m. Sunday. The location will stock Trulieve in-house brands and partner brands exclusive to Trulieve in Florida. Veterans receive 20% off and first-time guests are eligible for a 60% new customer discount.
Trulieve (OTCQX: TCNNF) applauded the Trump Administration decision on Dec 18, 2025 to reclassify marijuana to Schedule III under the Controlled Substances Act.
The company says rescheduling does not legalize marijuana but will ease federal research barriers, and — because Section 280E applies only to Schedule I/II — could remove the punitive 280E tax burden/b for state-legal operators. Trulieve also emphasized retained law-enforcement authority to target illicit operators and foreign cartels.
Trulieve (OTCQX: TCNNF) closed a US$140.0 million private placement of 10.5% Senior Secured Notes due December 17, 2030. The Notes were issued at 100% of face value, bear interest at 10.5% per annum payable semi-annually, and are senior secured obligations. The offering size was increased due to market demand and was completed on a best-efforts basis with Canaccord Genuity as sole agent and bookrunner.
The company intends to use net proceeds for capital expenditures and general corporate purposes. The Notes may be redeemed in whole or in part on or after December 17, 2027. The company has applied to list the Notes on the Canadian Securities Exchange following the four-month hold period.
Trulieve (OTCQX: TCNNF) announced a new Trulieve-branded dispensary opening in Findlay, Ohio on December 19, 2025, operated by Harvest Grows LLC under a licensing agreement.
The store at 1501 W Main Cross Street will be open 8 a.m.–9 p.m. daily and offer walk-in and express pickup, promotional grand opening specials, and Trulieve products including Modern Flower and R.O. brands across multiple form factors.
Harvest Grows currently operates two other Trulieve-branded Ohio locations (Cincinnati and Lorain), and Trulieve operates several owned Ohio dispensaries listed in the announcement.